news1

Research progress and clinical significance of drug components in snake venom

Defibrase is currently approved by the State Food and Drug Administration
For clinical application, it is derived from Agkistrodon acutus (Atracter acutus, known as Ar
Agkistrodon halys Pallas (Gf0, Bilin 6I! D, secreted at the exit of Lisi) ¨ “, mainly used for acute cerebral embolism
The treatment of coronary heart disease, hyperviscosity and hyperlipidemia
It has some applications.
Agkistrodon acutus enzyme is an antithrombotic fibrinolytic enzyme independently developed and applied in China
The medicine comes from Agkistrodon acutus. Clinically, snake venom fibrinolytic enzyme is mainly used for treatment
Thrombotic diseases also have certain effects on coronary heart disease and myocardial infarction. For acute phase
After treatment with fibrinolytic enzyme in patients with cerebral infarction, the neurological function of patients can be reduced


Post time: Feb-09-2023